Consistent with these in vitro data, our in vivo analysis of PKD1 expression in 152 ERα-positive breast tumours from tamoxifen-treated patients showed that high PKD1 expression is associated with less tamoxifen responsiveness. This evidence concerns the gene PKD1 and breast neoplasm.